SCHEMBL8438044

SCHEMBL8438044

Nc1ccc(COC(=O)N2CCCCC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ NPC1 O15118 4/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ TPSAB1 Q15661 3/20 0.47
▸ TPSD1 Q9BZJ3 3/20 0.47
▸ TPSG1 Q9NRR2 3/20 0.47
▸ PPID Q08752 1/20 0.47
▸ PRSS1 P07477 2/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ POLB P06746 1/20 0.46
▸ F2 P00734 1/20 0.43
▸ PLG P00747 1/20 0.43
▸ PRSS2 P07478 1/20 0.43
▸ PRSS3 P35030 1/20 0.43
▸ MAPT P10636 2/20 0.42
▸ GRIN2B Q13224 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17542431 0.95 SMN1; SMN2 (0.51) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL10170255 0.87 SMN1; SMN2 (0.50) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL27675677 0.84 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL543584 0.84 RAB9A (0.58) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL27797455 0.84 MEN1 (0.50) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL543263 0.84 SMN1; SMN2 (0.59) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL19942398 0.84 KMT2A (0.57) SMN1; SMN2MEN1KMT2ANPSR1NPC1
SCHEMBL16825229 0.84 GRIN2B (0.54) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL6557909 0.83 MEN1 (0.69) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL4710641 0.83 MEN1 (0.69) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977135-A Bicyclic heterocycles ZENECA LTD. (GB) 1999-11-02 — — US disclosed
EP-0846110-A1 THF-CONTAINING SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE Vertex Pharmaceuticals Incorporated (US) 1998-06-10 — — EP disclosed
CN-1181755-A THF-containing sulfonamides as aspartyl protease inhibitors VERTEX PHARMA (US) 1998-05-13 — — CN disclosed
EP-0733051-A1 BICYCLIC HETEROCYCLES AS NEUROKININ A ANTAGONISTS ZENECA LIMITED (GB) 1996-09-25 — — EP disclosed
EP-0667858-A1 4-CARBOXOAMIDO PIPERIDINE DERIVATIVES, INTERMEDIATES AND USE AS NEUROKININ ANTAGONISTS ZENECA LIMITED (GB) 1995-08-23 — — EP disclosed
Send feedback